BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3464164)

  • 1. Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
    Sinkeler S; Joosten E; Wevers R; Binkhorst R; Oei L
    Adv Exp Med Biol; 1986; 195 Pt B():517-23. PubMed ID: 3464164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
    Sinkeler SP; Joosten EM; Wevers RA; Binkhorst RA; Oerlemans FT; van Bennekom CA; Coerwinkel MM; Oei TL
    Clin Sci (Lond); 1986 Apr; 70(4):399-401. PubMed ID: 3457669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
    Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
    J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
    Heller SL; Kaiser KK; Planer GJ; Hagberg JM; Brooke MH
    Neurology; 1987 Jun; 37(6):1039-42. PubMed ID: 3473311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoadenylate deaminase deficiency and forearm ischemic exercise testing.
    Valen PA; Nakayama DA; Veum J; Sulaiman AR; Wortmann RL
    Arthritis Rheum; 1987 Jun; 30(6):661-8. PubMed ID: 3606685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.
    Patterson VH; Kaiser KK; Brooke MH
    Neurology; 1983 Jun; 33(6):784-6. PubMed ID: 6682523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoadenylate deaminase deficiency: diagnosis by forearm ischemic exercise testing.
    Valen PA; Nakayama DA; Veum JA; Wortmann RL
    Adv Exp Med Biol; 1986; 195 Pt B():525-8. PubMed ID: 3766241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH; Patterson VH; Kaiser KK
    Muscle Nerve; 1983; 6(3):204-6. PubMed ID: 6574314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
    Bertorini TE; Shively V; Taylor B; Palmieri GM; Fox IH
    Neurology; 1985 Sep; 35(9):1355-7. PubMed ID: 3860749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased ammonia production during forearm ischemic work test in McArdle's disease.
    Rumpf KW; Wagner H; Kaiser H; Meinck HM; Goebel HH; Scheler F
    Klin Wochenschr; 1981 Dec; 59(23):1319-20. PubMed ID: 6947119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoadenylate deaminase deficiency: an enzyme defect in search of a disease.
    Joosten E; van Bennekom C; Oerlemans F; De Bruyn C; Oei T; Trijbels J
    Adv Exp Med Biol; 1984; 165 Pt A():85-9. PubMed ID: 6720421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.
    Zöllner N; Reiter S; Gross M; Pongratz D; Reimers CD; Gerbitz K; Paetzke I; Deufel T; Hübner G
    Klin Wochenschr; 1986 Dec; 64(24):1281-90. PubMed ID: 3102830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
    N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
    Sabina RL; Swain JL; Patten BM; Ashizawa T; O'Brien WE; Holmes EW
    J Clin Invest; 1980 Dec; 66(6):1419-23. PubMed ID: 7440723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue adenosine content in active soleus and gracilis muscles of cats.
    Bockman EL; McKenzie JE
    Am J Physiol; 1983 Apr; 244(4):H552-9. PubMed ID: 6301292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise.
    Sinkeler SP; Binkhorst RA; Joosten EM; Wevers RA; Coerwinkei MM; Oei TL
    Clin Sci (Lond); 1987 Apr; 72(4):475-82. PubMed ID: 3829596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucose metabolism during muscular exercise in McArdle's disease].
    Krzentowski G; Pallikarakis N; Pirnay F
    Acta Clin Belg; 1979; 34(3):151-7. PubMed ID: 292291
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of ATP catabolism induced by deoxyadenosine and other nucleosides in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Adv Exp Med Biol; 1989; 253B():267-74. PubMed ID: 2558538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.